
Shareholding31 Oct 2026, 11:31 am
HDFC Mutual Fund Sells Piramal Pharma Shares
AI Summary
HDFC Mutual Fund has reduced its shareholding in Piramal Pharma Limited by 2.027%. Previously holding 7.015% of the paid-up equity share capital, the aggregate holding of HDFC Mutual Fund schemes now stands at 4.988% as of October 28, 2026. The transaction involved the sale of 2,69,92,907 shares.
Key Highlights
- HDFC Mutual Fund sold 2.027% stake in Piramal Pharma.
- Holding reduced from 7.015% to 4.988%.
- Sale involved 2,69,92,907 equity shares.
- Transaction occurred on October 28, 2026.
- Disclosure made under SEBI SAST Regulations, 2011.
Price Impact
More from PPLPHARMA